Finnegan Kevin 4
4 · New York & Company, Inc. · Filed Apr 24, 2012
Insider Transaction Report
Form 4
Finnegan Kevin
EVP, Global Sales & Operations
Transactions
- Award
Stock Appreciation Rights
2012-04-20+50,000→ 50,000 totalExercise: $3.65Exp: 2022-04-16→ Common Stock (50,000 underlying) - Award
Common Stock
2012-04-20+10,000→ 223,800 total
Holdings
- 8,919
Options to Purchase Common Stock
Exercise: $3.28Exp: 2017-03-21→ Common Stock (8,919 underlying) - 4,372(indirect: By Trust)
Common Stock
- 20,000
Options to Purchase Common Stock
Exercise: $4.74Exp: 2018-03-19→ Common Stock (20,000 underlying) - 50,000
Stock Appreciation Rights
Exercise: $4.79Exp: 2020-04-01→ Common Stock (50,000 underlying) - 30,000
Options to Purchase Common Stock
Exercise: $2.86Exp: 2019-03-18→ Common Stock (30,000 underlying) - 40,000
Stock Appreciation Rights
Exercise: $6.89Exp: 2021-04-15→ Common Stock (40,000 underlying)
Footnotes (8)
- [F1]The reporting person was awarded restricted stock which vests on April 16, 2015.
- [F2]In addition to the 10,000 shares of restricted stock referenced in footnote 1, includes 128,800 shares of common stock, 7,500 shares of restricted stock which vests on April 15, 2014, 75,000 shares of restricted stock which vests on April 1, 2013 and 2,500 shares of restricted stock that vests on June 24, 2012.
- [F3]Represents common stock indirectly beneficially owned through the Kevin L. Finnegan 2004 Grantor Retained Annuity Trust.
- [F4]The stock appreciation rights (SARs) vest on April 15, 2014. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
- [F5]The SARs vest on April 1, 2013. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
- [F6]The options become exercisable in four annual installments on the following dates: 7,500 shares on March 18, 2010; 7,500 shares on March 18, 2011; 7,500 shares on March 18, 2012; and 7,500 shares on March 18, 2013.
- [F7]The options are exercisable.
- [F8]The reporting person was awarded SARs which vest on April 16, 2015. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.